Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality.

The global Antibiotic Resistance market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Antibiotic Resistance, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Antibiotic Resistance, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Antibiotic Resistance, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibiotic Resistance sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Antibiotic Resistance market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Antibiotic Resistance sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Antibiotic Resistance Market Report

Report Metric	Details
Report Name	Antibiotic Resistance Market
CAGR	5%
Segment by Type	By Disease By Pathogen
Segment by Application	Oxazolidinones Lipoglycopeptides Tetracyclines Cephalosporins Combination therapies Other
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BioVersys GmbH, Macrolide Pharmaceuticals, Melinta Therapeutics, Merck, Nabriva Therapeutics, Nemesis Bioscience, Phage Technologies S.A, Tetraphase Pharmaceuticals, The Medicines Company, TPfizer, Westway Health
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Antibiotic Resistance in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Antibiotic Resistance manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibiotic Resistance sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Antibiotic Resistance Market report?

Ans: The main players in the Antibiotic Resistance Market are BioVersys GmbH, Macrolide Pharmaceuticals, Melinta Therapeutics, Merck, Nabriva Therapeutics, Nemesis Bioscience, Phage Technologies S.A, Tetraphase Pharmaceuticals, The Medicines Company, TPfizer, Westway Health

What are the Application segmentation covered in the Antibiotic Resistance Market report?

Ans: The Applications covered in the Antibiotic Resistance Market report are Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination therapies, Other

What are the Type segmentation covered in the Antibiotic Resistance Market report?

Ans: The Types covered in the Antibiotic Resistance Market report are By Disease, By Pathogen

1 Study Coverage

1.1 Antibiotic Resistance Product Introduction

1.2 Market by Type

1.2.1 Global Antibiotic Resistance Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 By Disease

1.2.3 By Pathogen

1.3 Market by Application

1.3.1 Global Antibiotic Resistance Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Oxazolidinones

1.3.3 Lipoglycopeptides

1.3.4 Tetracyclines

1.3.5 Cephalosporins

1.3.6 Combination therapies

1.3.7 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Antibiotic Resistance Sales Estimates and Forecasts 2019-2030

2.2 Global Antibiotic Resistance Revenue by Region

2.2.1 Global Antibiotic Resistance Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Antibiotic Resistance Revenue by Region (2019-2024)

2.2.3 Global Antibiotic Resistance Revenue by Region (2025-2030)

2.2.4 Global Antibiotic Resistance Revenue Market Share by Region (2019-2030)

2.3 Global Antibiotic Resistance Sales Estimates and Forecasts 2019-2030

2.4 Global Antibiotic Resistance Sales by Region

2.4.1 Global Antibiotic Resistance Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Antibiotic Resistance Sales by Region (2019-2024)

2.4.3 Global Antibiotic Resistance Sales by Region (2025-2030)

2.4.4 Global Antibiotic Resistance Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Antibiotic Resistance Sales by Manufacturers

3.1.1 Global Antibiotic Resistance Sales by Manufacturers (2019-2024)

3.1.2 Global Antibiotic Resistance Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antibiotic Resistance in 2023

3.2 Global Antibiotic Resistance Revenue by Manufacturers

3.2.1 Global Antibiotic Resistance Revenue by Manufacturers (2019-2024)

3.2.2 Global Antibiotic Resistance Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Antibiotic Resistance Revenue in 2023

3.3 Global Key Players of Antibiotic Resistance, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Antibiotic Resistance Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Antibiotic Resistance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Antibiotic Resistance, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Antibiotic Resistance, Product Offered and Application

3.8 Global Key Manufacturers of Antibiotic Resistance, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Antibiotic Resistance Sales by Type

4.1.1 Global Antibiotic Resistance Historical Sales by Type (2019-2024)

4.1.2 Global Antibiotic Resistance Forecasted Sales by Type (2025-2030)

4.1.3 Global Antibiotic Resistance Sales Market Share by Type (2019-2030)

4.2 Global Antibiotic Resistance Revenue by Type

4.2.1 Global Antibiotic Resistance Historical Revenue by Type (2019-2024)

4.2.2 Global Antibiotic Resistance Forecasted Revenue by Type (2025-2030)

4.2.3 Global Antibiotic Resistance Revenue Market Share by Type (2019-2030)

4.3 Global Antibiotic Resistance Price by Type

4.3.1 Global Antibiotic Resistance Price by Type (2019-2024)

4.3.2 Global Antibiotic Resistance Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Antibiotic Resistance Sales by Application

5.1.1 Global Antibiotic Resistance Historical Sales by Application (2019-2024)

5.1.2 Global Antibiotic Resistance Forecasted Sales by Application (2025-2030)

5.1.3 Global Antibiotic Resistance Sales Market Share by Application (2019-2030)

5.2 Global Antibiotic Resistance Revenue by Application

5.2.1 Global Antibiotic Resistance Historical Revenue by Application (2019-2024)

5.2.2 Global Antibiotic Resistance Forecasted Revenue by Application (2025-2030)

5.2.3 Global Antibiotic Resistance Revenue Market Share by Application (2019-2030)

5.3 Global Antibiotic Resistance Price by Application

5.3.1 Global Antibiotic Resistance Price by Application (2019-2024)

5.3.2 Global Antibiotic Resistance Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Antibiotic Resistance Market Size by Type

6.1.1 US & Canada Antibiotic Resistance Sales by Type (2019-2030)

6.1.2 US & Canada Antibiotic Resistance Revenue by Type (2019-2030)

6.2 US & Canada Antibiotic Resistance Market Size by Application

6.2.1 US & Canada Antibiotic Resistance Sales by Application (2019-2030)

6.2.2 US & Canada Antibiotic Resistance Revenue by Application (2019-2030)

6.3 US & Canada Antibiotic Resistance Market Size by Country

6.3.1 US & Canada Antibiotic Resistance Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Antibiotic Resistance Sales by Country (2019-2030)

6.3.3 US & Canada Antibiotic Resistance Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Antibiotic Resistance Market Size by Type

7.1.1 Europe Antibiotic Resistance Sales by Type (2019-2030)

7.1.2 Europe Antibiotic Resistance Revenue by Type (2019-2030)

7.2 Europe Antibiotic Resistance Market Size by Application

7.2.1 Europe Antibiotic Resistance Sales by Application (2019-2030)

7.2.2 Europe Antibiotic Resistance Revenue by Application (2019-2030)

7.3 Europe Antibiotic Resistance Market Size by Country

7.3.1 Europe Antibiotic Resistance Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Antibiotic Resistance Sales by Country (2019-2030)

7.3.3 Europe Antibiotic Resistance Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Antibiotic Resistance Market Size

8.1.1 China Antibiotic Resistance Sales (2019-2030)

8.1.2 China Antibiotic Resistance Revenue (2019-2030)

8.2 China Antibiotic Resistance Market Size by Application

8.2.1 China Antibiotic Resistance Sales by Application (2019-2030)

8.2.2 China Antibiotic Resistance Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Antibiotic Resistance Market Size by Type

9.1.1 Asia Antibiotic Resistance Sales by Type (2019-2030)

9.1.2 Asia Antibiotic Resistance Revenue by Type (2019-2030)

9.2 Asia Antibiotic Resistance Market Size by Application

9.2.1 Asia Antibiotic Resistance Sales by Application (2019-2030)

9.2.2 Asia Antibiotic Resistance Revenue by Application (2019-2030)

9.3 Asia Antibiotic Resistance Sales by Region

9.3.1 Asia Antibiotic Resistance Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Antibiotic Resistance Revenue by Region (2019-2030)

9.3.3 Asia Antibiotic Resistance Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Antibiotic Resistance Market Size by Type

10.1.1 Middle East, Africa and Latin America Antibiotic Resistance Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Antibiotic Resistance Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Antibiotic Resistance Market Size by Application

10.2.1 Middle East, Africa and Latin America Antibiotic Resistance Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Antibiotic Resistance Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Antibiotic Resistance Sales by Country

10.3.1 Middle East, Africa and Latin America Antibiotic Resistance Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Antibiotic Resistance Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Antibiotic Resistance Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Allergan

11.1.1 Allergan Company Information

11.1.2 Allergan Overview

11.1.3 Allergan Antibiotic Resistance Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Allergan Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Allergan Recent Developments

11.2 AmpliPhi Biosciences

11.2.1 AmpliPhi Biosciences Company Information

11.2.2 AmpliPhi Biosciences Overview

11.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 AmpliPhi Biosciences Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 AmpliPhi Biosciences Recent Developments

11.3 BioVersys GmbH

11.3.1 BioVersys GmbH Company Information

11.3.2 BioVersys GmbH Overview

11.3.3 BioVersys GmbH Antibiotic Resistance Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 BioVersys GmbH Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 BioVersys GmbH Recent Developments

11.4 Macrolide Pharmaceuticals

11.4.1 Macrolide Pharmaceuticals Company Information

11.4.2 Macrolide Pharmaceuticals Overview

11.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Macrolide Pharmaceuticals Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Macrolide Pharmaceuticals Recent Developments

11.5 Melinta Therapeutics

11.5.1 Melinta Therapeutics Company Information

11.5.2 Melinta Therapeutics Overview

11.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Melinta Therapeutics Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Melinta Therapeutics Recent Developments

11.6 Merck

11.6.1 Merck Company Information

11.6.2 Merck Overview

11.6.3 Merck Antibiotic Resistance Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Merck Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Merck Recent Developments

11.7 Nabriva Therapeutics

11.7.1 Nabriva Therapeutics Company Information

11.7.2 Nabriva Therapeutics Overview

11.7.3 Nabriva Therapeutics Antibiotic Resistance Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Nabriva Therapeutics Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Nabriva Therapeutics Recent Developments

11.8 Nemesis Bioscience

11.8.1 Nemesis Bioscience Company Information

11.8.2 Nemesis Bioscience Overview

11.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Nemesis Bioscience Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Nemesis Bioscience Recent Developments

11.9 Phage Technologies S.A

11.9.1 Phage Technologies S.A Company Information

11.9.2 Phage Technologies S.A Overview

11.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Phage Technologies S.A Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Phage Technologies S.A Recent Developments

11.10 Tetraphase Pharmaceuticals

11.10.1 Tetraphase Pharmaceuticals Company Information

11.10.2 Tetraphase Pharmaceuticals Overview

11.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Tetraphase Pharmaceuticals Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Tetraphase Pharmaceuticals Recent Developments

11.11 The Medicines Company

11.11.1 The Medicines Company Company Information

11.11.2 The Medicines Company Overview

11.11.3 The Medicines Company Antibiotic Resistance Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 The Medicines Company Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 The Medicines Company Recent Developments

11.12 TPfizer

11.12.1 TPfizer Company Information

11.12.2 TPfizer Overview

11.12.3 TPfizer Antibiotic Resistance Sales, Price, Revenue and Gross Margin (2019-2024)

11.12.4 TPfizer Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 TPfizer Recent Developments

11.13 Westway Health

11.13.1 Westway Health Company Information

11.13.2 Westway Health Overview

11.13.3 Westway Health Antibiotic Resistance Sales, Price, Revenue and Gross Margin (2019-2024)

11.13.4 Westway Health Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Westway Health Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Antibiotic Resistance Industry Chain Analysis

12.2 Antibiotic Resistance Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Antibiotic Resistance Production Mode & Process

12.4 Antibiotic Resistance Sales and Marketing

12.4.1 Antibiotic Resistance Sales Channels

12.4.2 Antibiotic Resistance Distributors

12.5 Antibiotic Resistance Customers

13 Market Dynamics

13.1 Antibiotic Resistance Industry Trends

13.2 Antibiotic Resistance Market Drivers

13.3 Antibiotic Resistance Market Challenges

13.4 Antibiotic Resistance Market Restraints

14 Key Findings in The Global Antibiotic Resistance Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Allergan plc

AmpliPhi Biosciences

BioVersys GmbH

Macrolide Pharmaceuticals

Phage Technologies S.A

Tetraphase Pharmaceuticals

The Medicines Company

TPfizer

Westway Health

List of Tables

Table 1. Global Antibiotic Resistance Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Type I

Table 3. Major Manufacturers of Type II

Table 4. Global Antibiotic Resistance Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Antibiotic Resistance Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Antibiotic Resistance Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Antibiotic Resistance Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Antibiotic Resistance Revenue Market Share by Region (2019-2024)

Table 9. Global Antibiotic Resistance Revenue Market Share by Region (2025-2030)

Table 10. Global Antibiotic Resistance Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 11. Global Antibiotic Resistance Sales by Region (2019-2024) & (K Units)

Table 12. Global Antibiotic Resistance Sales by Region (2025-2030) & (K Units)

Table 13. Global Antibiotic Resistance Sales Market Share by Region (2019-2024)

Table 14. Global Antibiotic Resistance Sales Market Share by Region (2025-2030)

Table 15. Global Antibiotic Resistance Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Antibiotic Resistance Sales Share by Manufacturers (2019-2024)

Table 17. Global Antibiotic Resistance Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Antibiotic Resistance Revenue Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Antibiotic Resistance, Industry Ranking, 2022 VS 2023 VS 2024

Table 20. Antibiotic Resistance Price by Manufacturers 2019-2024 (USD/Unit)

Table 21. Global Antibiotic Resistance Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Antibiotic Resistance by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotic Resistance as of 2023)

Table 23. Global Key Manufacturers of Antibiotic Resistance, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Antibiotic Resistance, Product Offered and Application

Table 25. Global Key Manufacturers of Antibiotic Resistance, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Antibiotic Resistance Sales by Type (2019-2024) & (K Units)

Table 28. Global Antibiotic Resistance Sales by Type (2025-2030) & (K Units)

Table 29. Global Antibiotic Resistance Sales Share by Type (2019-2024)

Table 30. Global Antibiotic Resistance Sales Share by Type (2025-2030)

Table 31. Global Antibiotic Resistance Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Antibiotic Resistance Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Antibiotic Resistance Revenue Share by Type (2019-2024)

Table 34. Global Antibiotic Resistance Revenue Share by Type (2025-2030)

Table 35. Antibiotic Resistance Price by Type (2019-2024) & (USD/Unit)

Table 36. Global Antibiotic Resistance Price Forecast by Type (2025-2030) & (USD/Unit)

Table 37. Global Antibiotic Resistance Sales by Application (2019-2024) & (K Units)

Table 38. Global Antibiotic Resistance Sales by Application (2025-2030) & (K Units)

Table 39. Global Antibiotic Resistance Sales Share by Application (2019-2024)

Table 40. Global Antibiotic Resistance Sales Share by Application (2025-2030)

Table 41. Global Antibiotic Resistance Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Antibiotic Resistance Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Antibiotic Resistance Revenue Share by Application (2019-2024)

Table 44. Global Antibiotic Resistance Revenue Share by Application (2025-2030)

Table 45. Antibiotic Resistance Price by Application (2019-2024) & (USD/Unit)

Table 46. Global Antibiotic Resistance Price Forecast by Application (2025-2030) & (USD/Unit)

Table 47. US & Canada Antibiotic Resistance Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Antibiotic Resistance Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Antibiotic Resistance Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Antibiotic Resistance Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Antibiotic Resistance Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Antibiotic Resistance Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Antibiotic Resistance Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Antibiotic Resistance Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Antibiotic Resistance Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Antibiotic Resistance Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Antibiotic Resistance Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Antibiotic Resistance Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Antibiotic Resistance Sales by Country (2025-2030) & (K Units)

Table 60. Europe Antibiotic Resistance Sales by Type (2019-2024) & (K Units)

Table 61. Europe Antibiotic Resistance Sales by Type (2025-2030) & (K Units)

Table 62. Europe Antibiotic Resistance Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Antibiotic Resistance Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Antibiotic Resistance Sales by Application (2019-2024) & (K Units)

Table 65. Europe Antibiotic Resistance Sales by Application (2025-2030) & (K Units)

Table 66. Europe Antibiotic Resistance Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Antibiotic Resistance Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Antibiotic Resistance Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Antibiotic Resistance Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Antibiotic Resistance Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Antibiotic Resistance Sales by Country (2019-2024) & (K Units)

Table 72. Europe Antibiotic Resistance Sales by Country (2025-2030) & (K Units)

Table 73. China Antibiotic Resistance Sales by Type (2019-2024) & (K Units)

Table 74. China Antibiotic Resistance Sales by Type (2025-2030) & (K Units)

Table 75. China Antibiotic Resistance Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Antibiotic Resistance Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Antibiotic Resistance Sales by Application (2019-2024) & (K Units)

Table 78. China Antibiotic Resistance Sales by Application (2025-2030) & (K Units)

Table 79. China Antibiotic Resistance Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Antibiotic Resistance Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Antibiotic Resistance Sales by Type (2019-2024) & (K Units)

Table 82. Asia Antibiotic Resistance Sales by Type (2025-2030) & (K Units)

Table 83. Asia Antibiotic Resistance Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Antibiotic Resistance Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Antibiotic Resistance Sales by Application (2019-2024) & (K Units)

Table 86. Asia Antibiotic Resistance Sales by Application (2025-2030) & (K Units)

Table 87. Asia Antibiotic Resistance Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Antibiotic Resistance Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Antibiotic Resistance Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Antibiotic Resistance Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Antibiotic Resistance Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Antibiotic Resistance Sales by Region (2019-2024) & (K Units)

Table 93. Asia Antibiotic Resistance Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Antibiotic Resistance Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Antibiotic Resistance Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Antibiotic Resistance Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Antibiotic Resistance Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Antibiotic Resistance Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Antibiotic Resistance Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Antibiotic Resistance Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Antibiotic Resistance Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Antibiotic Resistance Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Antibiotic Resistance Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Antibiotic Resistance Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Antibiotic Resistance Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Antibiotic Resistance Sales by Country (2025-2030) & (K Units)

Table 107. Allergan Company Information

Table 108. Allergan Description and Major Businesses

Table 109. Allergan Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 110. Allergan Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Allergan Recent Developments

Table 112. AmpliPhi Biosciences Company Information

Table 113. AmpliPhi Biosciences Description and Major Businesses

Table 114. AmpliPhi Biosciences Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 115. AmpliPhi Biosciences Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. AmpliPhi Biosciences Recent Developments

Table 117. BioVersys GmbH Company Information

Table 118. BioVersys GmbH Description and Major Businesses

Table 119. BioVersys GmbH Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 120. BioVersys GmbH Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. BioVersys GmbH Recent Developments

Table 122. Macrolide Pharmaceuticals Company Information

Table 123. Macrolide Pharmaceuticals Description and Major Businesses

Table 124. Macrolide Pharmaceuticals Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 125. Macrolide Pharmaceuticals Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Macrolide Pharmaceuticals Recent Developments

Table 127. Melinta Therapeutics Company Information

Table 128. Melinta Therapeutics Description and Major Businesses

Table 129. Melinta Therapeutics Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 130. Melinta Therapeutics Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Melinta Therapeutics Recent Developments

Table 132. Merck Company Information

Table 133. Merck Description and Major Businesses

Table 134. Merck Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 135. Merck Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Merck Recent Developments

Table 137. Nabriva Therapeutics Company Information

Table 138. Nabriva Therapeutics Description and Major Businesses

Table 139. Nabriva Therapeutics Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 140. Nabriva Therapeutics Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Nabriva Therapeutics Recent Developments

Table 142. Nemesis Bioscience Company Information

Table 143. Nemesis Bioscience Description and Major Businesses

Table 144. Nemesis Bioscience Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 145. Nemesis Bioscience Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Nemesis Bioscience Recent Developments

Table 147. Phage Technologies S.A Company Information

Table 148. Phage Technologies S.A Description and Major Businesses

Table 149. Phage Technologies S.A Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 150. Phage Technologies S.A Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. Phage Technologies S.A Recent Developments

Table 152. Tetraphase Pharmaceuticals Company Information

Table 153. Tetraphase Pharmaceuticals Description and Major Businesses

Table 154. Tetraphase Pharmaceuticals Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 155. Tetraphase Pharmaceuticals Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Tetraphase Pharmaceuticals Recent Developments

Table 157. The Medicines Company Company Information

Table 158. The Medicines Company Description and Major Businesses

Table 159. The Medicines Company Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 160. The Medicines Company Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

Table 161. The Medicines Company Recent Developments

Table 162. TPfizer Company Information

Table 163. TPfizer Description and Major Businesses

Table 164. TPfizer Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 165. TPfizer Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

Table 166. TPfizer Recent Developments

Table 167. Westway Health Company Information

Table 168. Westway Health Description and Major Businesses

Table 169. Westway Health Antibiotic Resistance Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 170. Westway Health Antibiotic Resistance Product Model Numbers, Pictures, Descriptions and Specifications

Table 171. Westway Health Recent Developments

Table 172. Key Raw Materials Lists

Table 173. Raw Materials Key Suppliers Lists

Table 174. Antibiotic Resistance Distributors List

Table 175. Antibiotic Resistance Customers List

Table 176. Antibiotic Resistance Market Trends

Table 177. Antibiotic Resistance Market Drivers

Table 178. Antibiotic Resistance Market Challenges

Table 179. Antibiotic Resistance Market Restraints

Table 180. Research Programs/Design for This Report

Table 181. Key Data Information from Secondary Sources

Table 182. Key Data Information from Primary Sources

List of Figures

Figure 1. Antibiotic Resistance Product Picture

Figure 2. Global Antibiotic Resistance Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Antibiotic Resistance Market Share by Type in 2023 & 2030

Figure 4. Type I Product Picture

Figure 5. Type II Product Picture

Figure 6. Global Antibiotic Resistance Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Antibiotic Resistance Market Share by Application in 2023 & 2030

Figure 8. Oxazolidinones

Figure 9. Lipoglycopeptides

Figure 10. Tetracyclines

Figure 11. Cephalosporins

Figure 12. Combination therapies

Figure 13. Other

Figure 14. Antibiotic Resistance Report Years Considered

Figure 15. Global Antibiotic Resistance Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Antibiotic Resistance Revenue 2019-2030 (US$ Million)

Figure 17. Global Antibiotic Resistance Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 18. Global Antibiotic Resistance Revenue Market Share by Region (2019-2030)

Figure 19. Global Antibiotic Resistance Sales 2019-2030 ((K Units)

Figure 20. Global Antibiotic Resistance Sales Market Share by Region (2019-2030)

Figure 21. US & Canada Antibiotic Resistance Sales YoY (2019-2030) & (K Units)

Figure 22. US & Canada Antibiotic Resistance Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Europe Antibiotic Resistance Sales YoY (2019-2030) & (K Units)

Figure 24. Europe Antibiotic Resistance Revenue YoY (2019-2030) & (US$ Million)

Figure 25. China Antibiotic Resistance Sales YoY (2019-2030) & (K Units)

Figure 26. China Antibiotic Resistance Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Asia (excluding China) Antibiotic Resistance Sales YoY (2019-2030) & (K Units)

Figure 28. Asia (excluding China) Antibiotic Resistance Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Antibiotic Resistance Sales YoY (2019-2030) & (K Units)

Figure 30. Middle East, Africa and Latin America Antibiotic Resistance Revenue YoY (2019-2030) & (US$ Million)

Figure 31. The Antibiotic Resistance Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. The Top 5 and 10 Largest Manufacturers of Antibiotic Resistance in the World: Market Share by Antibiotic Resistance Revenue in 2023

Figure 33. Global Antibiotic Resistance Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 34. Global Antibiotic Resistance Sales Market Share by Type (2019-2030)

Figure 35. Global Antibiotic Resistance Revenue Market Share by Type (2019-2030)

Figure 36. Global Antibiotic Resistance Sales Market Share by Application (2019-2030)

Figure 37. Global Antibiotic Resistance Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Antibiotic Resistance Sales Market Share by Type (2019-2030)

Figure 39. US & Canada Antibiotic Resistance Revenue Market Share by Type (2019-2030)

Figure 40. US & Canada Antibiotic Resistance Sales Market Share by Application (2019-2030)

Figure 41. US & Canada Antibiotic Resistance Revenue Market Share by Application (2019-2030)

Figure 42. US & Canada Antibiotic Resistance Revenue Share by Country (2019-2030)

Figure 43. US & Canada Antibiotic Resistance Sales Share by Country (2019-2030)

Figure 44. U.S. Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 45. Canada Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 46. Europe Antibiotic Resistance Sales Market Share by Type (2019-2030)

Figure 47. Europe Antibiotic Resistance Revenue Market Share by Type (2019-2030)

Figure 48. Europe Antibiotic Resistance Sales Market Share by Application (2019-2030)

Figure 49. Europe Antibiotic Resistance Revenue Market Share by Application (2019-2030)

Figure 50. Europe Antibiotic Resistance Revenue Share by Country (2019-2030)

Figure 51. Europe Antibiotic Resistance Sales Share by Country (2019-2030)

Figure 52. Germany Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 53. France Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 54. U.K. Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 55. Italy Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 56. Russia Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 57. China Antibiotic Resistance Sales Market Share by Type (2019-2030)

Figure 58. China Antibiotic Resistance Revenue Market Share by Type (2019-2030)

Figure 59. China Antibiotic Resistance Sales Market Share by Application (2019-2030)

Figure 60. China Antibiotic Resistance Revenue Market Share by Application (2019-2030)

Figure 61. Asia Antibiotic Resistance Sales Market Share by Type (2019-2030)

Figure 62. Asia Antibiotic Resistance Revenue Market Share by Type (2019-2030)

Figure 63. Asia Antibiotic Resistance Sales Market Share by Application (2019-2030)

Figure 64. Asia Antibiotic Resistance Revenue Market Share by Application (2019-2030)

Figure 65. Asia Antibiotic Resistance Revenue Share by Region (2019-2030)

Figure 66. Asia Antibiotic Resistance Sales Share by Region (2019-2030)

Figure 67. Japan Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 68. South Korea Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 69. China Taiwan Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 70. Southeast Asia Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 71. India Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 72. Middle East, Africa and Latin America Antibiotic Resistance Sales Market Share by Type (2019-2030)

Figure 73. Middle East, Africa and Latin America Antibiotic Resistance Revenue Market Share by Type (2019-2030)

Figure 74. Middle East, Africa and Latin America Antibiotic Resistance Sales Market Share by Application (2019-2030)

Figure 75. Middle East, Africa and Latin America Antibiotic Resistance Revenue Market Share by Application (2019-2030)

Figure 76. Middle East, Africa and Latin America Antibiotic Resistance Revenue Share by Country (2019-2030)

Figure 77. Middle East, Africa and Latin America Antibiotic Resistance Sales Share by Country (2019-2030)

Figure 78. Brazil Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 79. Mexico Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 80. Turkey Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 81. Israel Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 82. GCC Countries Antibiotic Resistance Revenue (2019-2030) & (US$ Million)

Figure 83. Antibiotic Resistance Value Chain

Figure 84. Antibiotic Resistance Production Process

Figure 85. Channels of Distribution

Figure 86. Distributors Profiles

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Combined Polio Vaccine Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-12Q18734

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Amebiasis Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-38D9688

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Pseudorabies Virus Vaccine Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-14B9979

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Malaria Rapid Diagnostic Device Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-16B9848

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions